ARTICLES

For years, the spine industry operated on one governing logic: optimize cost, maintain quality, keep inventory moving. It worked well enough that the supply chain became effectively invisible — titanium components, cobalt-chrome parts, PEEK-based products, instrument subassemblies, packaging — sourced across a global network refined over decades. Nobody questioned it much … [Read more...] about Trump’s Tariffs Didn’t Just Raise Costs. They Exposed How Fragile Spine’s Supply Chain Really Is

For years, the spine industry relied on a familiar commercial model. The best reps were not just salespeople. They were field operators, problem-solvers, surgeon supporters, and account stabilizers. They knew the procedure, managed the trays, anticipated problems in the OR, and built the kind of personal loyalty that often protected business for years. That model helped … [Read more...] about Why Spine’s Commercial Model Needs a Reset? The real elephant in the room may not be technology, but incentives

We first published this article in 2025. We are now republishing it in updated form following the latest FDA approval in the single-use spine market, including Dual, one of the newest additions to this category. Over the past two decades, spine surgery has evolved through advances in minimally invasive techniques, greater intraoperative precision, and a growing focus on … [Read more...] about Single-Use Spine Surgery Systems: The Future or Still a Niche? Leading Platforms in 2026

In MedTech, it is easy to misunderstand the role of marketing. This is a business built on relationships, service, clinical credibility, and product knowledge. Surgeons do not adopt a device because they saw a polished campaign. Hospitals do not change practice because of a clever slogan. And no brochure, however well designed, can replace the value of a strong rep in the … [Read more...] about In MedTech Sales, Does Marketing Really Matter? Yes, But Only If It Helps Sell

Turkey does not usually sit at the center of most EMEA spine market conversations, but it deserves more attention than it gets. Not because it is already one of the world’s largest spine markets in absolute value, but because it combines several growth drivers that rarely come together in one country: a large hospital base, near-universal health coverage, a meaningful private … [Read more...] about Why Turkey’s Spine Market Is Worth Watching | 2026 Update

The global minimally invasive sacroiliac joint fusion (MIS Sacroiliac Joint Fusion) market has become, in recent years, one of the fastest-growing segments within the spine implants market. This growth is mainly driven by the high prevalence of chronic lower back pain associated with sacroiliac joint dysfunction, a condition that was historically underdiagnosed but is now … [Read more...] about Top 60+ Minimally Invasive Sacroiliac Joint Fusion Systems (MIS) – 2026 Updated Guide

In medtech, including the spine business, few goals generate as much obsession as obtaining FDA clearance in the United States or CE marking under MDR in Europe. For many startups, that milestone eventually becomes the company’s central focus. Everything revolves around approval: the product, trials, documentation, investors, timelines, and resources. The problem is that … [Read more...] about The Regulatory Trap: FDA and MDR Are Milestones. They Are Not a Business Model

In spine surgery, cage subsidence is often framed as a radiographic complication or an implant-related event. Yet its real significance lies elsewhere. What makes subsidence important is not the image itself, but what it may reveal and what it may compromise. As the cage settles, disc height can decrease, indirect decompression may be reduced, segmental correction can be … [Read more...] about What Really Worries Surgeons About Subsidence? A practical industry perspective on what Cage Subsidence means in daily spine surgery

Buttress plates play a simple but important role in spine surgery. Rather than providing general fixation alone, they are mainly used to help keep a graft, cage, or reconstructed vertebral segment in place and to reduce the risk of migration after surgery. Their value is especially clear in procedures such as corpectomy, trauma cases, and other anterior reconstructions, where … [Read more...] about +10 Anterior Buttress Plates to Know…! | Updated 2026

The Argentine spine implants market is already big enough to support its own industrial base, a specialized commercial network, and a local competitive landscape worth watching. In 2024, the Argentine spinal implants market is estimated at USD 146.5 million, with a projection of USD 285.3 million by 2033 (7.8% compound annual growth rate). Within the market, the largest … [Read more...] about Beyond Imports: The Argentine Spine Manufacturers Shaping a Growing Market | 2026 Update

Globus Medical is not simply entering 2026 with an “aggressive” posture. It is attempting something structurally more ambitious: building a self-reinforcing spine ecosystem that compresses competitive space around it. This is not a growth story. It is a control story. Spine as the Economic Engine Roughly 95% of revenue still comes from spine. Over 80% of that from the … [Read more...] about Globus Medical’s Strategy: Building a Closed-Loop Spine Ecosystem

The mid-tier spine market is not quietly evolving. It is being compressed, reshaped and selectively strengthened by structural forces that increasingly reward scale, differentiation and capital discipline. What often appears to be routine M&A activity is, in reality, a multi-year sorting process that is steadily separating structurally advantaged players from those … [Read more...] about Who Is Really Winning the Mid-Tier Spine Consolidation?A Structural Map of the Competitive Landscape

Zavation Medical’s acquisition of ChoiceSpine looks like a strategically sound step within the ongoing consolidation of the spine mid-market. With private equity firm Gemspring Capital behind the deal, the rationale is familiar: bring together complementary platforms, expand commercial reach, improve EBITDA potential, and ultimately build a more valuable asset ahead of a future … [Read more...] about Behind the Deal: The Strategic Logic of Zavation’s ChoiceSpine Acquisition

With ESUBE's second masterclass taking place tomorrow (February 26–28, 2026), in Seville, Spain, it's worth looking at just how much spinal endoscopy has evolved. More hospitals are adopting these techniques, and there's been significant investment in research, what was once a highly specialized procedure is gradually becoming more routine in spine surgery. In this brief … [Read more...] about From Niche to Momentum: The Rapid Rise of Spinal Endoscopy — A Brief Market Update

J&J dropped the news yesterday that they're looking into selling off DePuy Synthes. Honestly, we've been calling this move ever since the spin-off wrapped up. But here's what everyone in the industry is really wondering about: Who could realistically buy an asset of this size and complexity? A rare… and complicated opportunity DePuy Synthes remains one of the leading … [Read more...] about DePuy Synthes for Sale: Who Could Actually Buy the Orthopedic Giant?

Powehi Medical, a young spine startup focused on fixation systems and less rigid stability concepts, recently experienced a situation far more common in MedTech than many founders initially expect. After receiving its first European patent grant, a Swiss spine company filed an opposition at the European Patent Office (EPO). This was not a lawsuit. For a startup, it can be … [Read more...] about Innovation on Hold: How EPO Oppositions Affect Spine Startups — The Powehi Medical Case

For years, spine surgery has been performed under the assumption of adequate bone quality: stiffer implants, larger corrections, more instrumented levels, and increasing use of MIS in older patients. But demographics changed before surgical philosophy did. Today, the typical degenerative case is less often a middle-aged disc herniation and increasingly an elderly patient. … [Read more...] about Most Spine Failures Are Predictable — The Bone Problem in Spine Surgery Nobody Budgets For

In less than a decade, expandable interbody cages have evolved from a niche concept into one of the fastest-growing segments in lumbar fusion. The global interbody cage market is estimated at roughly $3–3.5 billion annually, with expandable designs already representing a substantial portion of posterior lumbar procedures — corresponding to an estimated $700 million to $1.1 … [Read more...] about Expandable cages were adopted not because they fused better, but because they made fusion easier to perform. Review of 64 TLIF/PLIF Expandable Systems (2026 Update)

Expandable interbody cages have earned their place in modern lumbar fusion—not because they’re trendy, but because they’ve genuinely changed what surgeons can accomplish. The ability to restore disc height and segmental lordosis through controlled, in‑situ expansion has reshaped surgical strategy in meaningful ways. Add to that the smaller insertion profiles, reduced endplate … [Read more...] about Why Expandable Cages Sometimes Lose Lordosis After Lumbar Fusion